Allogene Therapeutics, Inc. (ALLO)

Typically moves ±5.95% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Allogene Therapeutics, Inc. (ALLO) has reported earnings 22 times since May 05, 2021. The stock moves an average of ±5.95% the day after reporting, closing higher 59.1% of the time. Its largest post-earnings gain was +17.85% (Nov 02, 2023) and its largest decline was -15.93% (May 13, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How ALLO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.95%

Positive %

59.1%

Negative %

40.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☽ POST	-3.65%	open_in_new
May 13, 2026	☽ POST	-7.31%	open_in_new
Mar 12, 2026	☽ POST	-2.83%	open_in_new
Nov 06, 2025	☽ POST	+12.38%	open_in_new
Aug 13, 2025	☽ POST	+2.88%	open_in_new
May 13, 2025	☽ POST	-15.93%	open_in_new
Mar 13, 2025	☽ POST	+2.65%	open_in_new
Nov 07, 2024	☽ POST	-3.45%	open_in_new
Aug 07, 2024	☽ POST	-4.45%	open_in_new
May 13, 2024	☽ POST	+2.07%	open_in_new
Mar 14, 2024	☽ POST	+3.56%	open_in_new
Nov 02, 2023	☽ POST	+17.85%	open_in_new
Aug 02, 2023	☽ POST	+9.59%	open_in_new
May 03, 2023	☽ POST	+12.76%	open_in_new
Feb 28, 2023	☽ POST	-0.16%	open_in_new
Nov 02, 2022	☽ POST	-6.39%	open_in_new
Aug 09, 2022	☽ POST	+7.78%	open_in_new
May 04, 2022	☽ POST	-1.91%	open_in_new
Feb 23, 2022	☽ POST	+0.87%	open_in_new
Nov 04, 2021	☽ POST	+3.65%	open_in_new
Aug 04, 2021	☽ POST	+7.23%	open_in_new
May 05, 2021	☽ POST	+1.6%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.95%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 26 →

Funds holding

$202088978

Total value held

Buying

22 added · 3 reduced

Blackrock, Inc.

$62705681 +57.91%

Pfizer Inc

$46928245 Held

State Street Corp

$39573718 +119.69%

Goldman Sachs Group Inc

$12789834 +122.29%

Morgan Stanley

$9380720 +351.52%

SEC Filing Types

description SCHEDULE 13G/A

19 chevron_right

description SC 13G

11 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260902	open_in_new SEC.gov
4	20260825	open_in_new SEC.gov
144	20260821	open_in_new SEC.gov
EFFECT	20260820	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
S-3	20260812	open_in_new SEC.gov
SCHEDULE 13G/A	20260807	open_in_new SEC.gov
SCHEDULE 13G	20260807	open_in_new SEC.gov

Frequently asked about ALLO earnings

When does Allogene Therapeutics, Inc. report earnings next? expand_more

Allogene Therapeutics, Inc. (ALLO)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ALLO stock move after earnings? expand_more

Over 22 reports, ALLO has moved an average of ±5.95% the session after earnings, closing higher 59.1% of the time.

What was ALLO's biggest post-earnings move? expand_more

ALLO's largest post-earnings gain on record was +17.85% on Nov 02, 2023, and its largest decline was -15.93% on May 13, 2025.

Where can I find Allogene Therapeutics, Inc.'s SEC filings? expand_more

All of Allogene Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.